Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway/Experiment 5/Signature 2
From BugSigDB
Reviewed Marked as Reviewed by Atrayees on 2023-7-14
Source: supp fig 2
Description: Bar plot of compositional differences at species level in the Control vs. Vanc group of mice before PD-1 antibody treatment by one-way ANOVA.
Abundance in Group 1: decreased abundance in Vanc
| NCBI | Quality Control | Links |
|---|---|---|
| Bacteroides sp. CAG:927 | ||
| Firmicutes bacterium ASF500 | ||
| Lachnospiraceae bacterium A4 | ||
| Phocaeicola massiliensis | ||
| Prevotella sp. CAG:1031 | ||
| Prevotella sp. CAG:873 |
Revision editor(s): Mary Bearkland
